All stock lists
Vor Biopharma Inc. (VOR)
NASDAQ: VOR · Real-Time Price · USD
Healthcare · Biotechnology
18.07-0.19 (-1.04%)
Insider Score
––Not scored
VOR Insider Score
Insiders here have filed 2 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
VOR Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Revenue Growth (YoY) | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — |
| SG&A Expense | 21.93 M | 17.57 M | 16.77 M | 13.96 M | 12.79 M | — |
| R&D Expense | 25.92 M | 17.59 M | 19.19 M | 14.14 M | 261.50 M | — |
| Operating Expenses | 47.85 M | 35.16 M | 35.96 M | 28.11 M | 274.28 M | — |
| Operating Income | -47.85 M | -35.16 M | -35.96 M | -28.11 M | -274.28 M | — |
| Pretax Income | -62.81 M | -219.59 M | 1.72 B | -812.68 M | -1.57 B | — |
| Tax Provision | — | — | — | — | — | — |
| Net Income | -62.81 M | -219.59 M | 1.72 B | -812.68 M | -1.57 B | — |
| EPS (Basic) | -1.16 | -5.11 | — | -121.63 | -251.24 | -5.21 |
| EPS (Diluted) | -1.16 | -5.11 | — | -121.63 | -251.24 | -5.21 |
| Shares Outstanding | 54.30 M | 43.01 M | — | 6.68 M | 6.26 M | 6.24 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.